CGC Stock Analysis: Buy, Sell, or Hold?
CGC - Canopy Growth Corporation Common Shares
$0.95
0.09 (10.80%)
▲
5d:
-0.99%
30d:
-11.29%
90d:
-21.55%
BUY
MODERATE Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 29, 2026
Smart Money Accumulation
CGC is down 8.9% this week, but smart money is accumulating calls. Top strike: $1 2026-05-01 with 123 OI. Call ratio: 71% View Scanner →
Strength: 6.6/10
Get Alerted When CGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CGC shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: CGC shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CGC is currently trading at $0.95, which is considered oversold relative to its 30-day fair value range of $0.96 to $1.12. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.8) compared to its historical average (13.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CGC is in a downtrend. Immediate support is located at $0.84, while resistance sits at $1.07. The stock is showing strong short-term momentum, up 10.8% recently.
Market Sentiment: CGC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.76 (+85.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CGC is in a downtrend. Immediate support is located at $0.84, while resistance sits at $1.07. The stock is showing strong short-term momentum, up 10.8% recently.
Market Sentiment: CGC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.76 (+85.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.96 -
$1.12
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.8%)
- BULLISH: Trading 85.7% below Wall St target ($1.76)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Fair Price Analysis
30-Day Fair Range
$0.96 -
$1.12
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.84
Resistance Level
$1.07
Current Trend
Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.76
Wall Street Target
$1.76
(+85.7%)
Revenue Growth (YoY)
-0.3%
Profit Margin
-117.3%
PE vs Historical
-2.8 vs 13.0
CHEAP
Share & Embed Analysis
Last updated: April 01, 2026 12:39 AM ET
Data refreshes hourly during market hours. Next update: 1:39 AM
Data refreshes hourly during market hours. Next update: 1:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Luc Mongeau
SELL
9376 shares
2026-02-11
Theresa Yanofsky
SELL
10434 shares
2025-12-31
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 64 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 57 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 65 BUY |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
Advanced CGC Option Strategies
Professional options setups generated by AI based on today's CGC price and gamma walls.
